Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

COI Investigators (Xi Li, Ruozheng Wang are the joint first authors) reported a comprehensive analysis of key immune checkpoint receptors on T cells in 172 treatment-naïve, primary cancer patients from the eight most prevalent types of cancer.

They have evaluated the expression of inhibitory receptors on tumor infiltrating T cells and paired blood samples from 172 primary cancer patients for their potential value in checkpoint blockade and their risk for causing autoimmune disease. 

(Li, et al, Frontiers in Oncology)

IMG_2052.JPG